InSilicoLynx

Curated by Signal

Chemoinformatic Technology Platform

Overview

InSilicoLynx has developed a technology platform, which offers an assessment of Toxicity and efficacy of the compound, and provides physicochemical and pharmacokinetic analysis. The technology has an integrated collection of ADME models, allowing it to predict plasma concentration. With the use of machine learning algorithms strategic design of the compound can be achieved against an estimated plasma level. The company is an early stage service provider in drug discovery.

Key facts

Founded: 2015
Headquarters: Macclesfield, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

CK Clinical
Online job portal for healthcare professionals
Health TechnologyHertfordshire, United Kingdom
Learning Labs
Provider of a digital learning platform for employees
Health TechnologyNewcastle Upon Tyne, United Kingdom
Healthcode
Provider of practice management software for clinics
Health TechnologyStaines upon Thames, United Kingdom

About InSilicoLynx

What does InSilicoLynx do?

InSilicoLynx has developed a technology platform, which offers an assessment of Toxicity and efficacy of the compound, and provides physicochemical and pharmacokinetic analysis.

Where is InSilicoLynx headquartered?

InSilicoLynx is headquartered in Macclesfield, United Kingdom.

When was InSilicoLynx founded?

InSilicoLynx was founded in 2015.

Which sector is InSilicoLynx in?

InSilicoLynx operates in Health Technology.

Who are InSilicoLynx's competitors?

Companies similar to InSilicoLynx include CK Clinical, Learning Labs, and Healthcode.